Abacavir: all 77 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- An Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in Children and Adolescents With HIV in AfricaNot yet recruitingNCT07792096Phase 3
- STARLITE for Unresectable High-Grade GliomasRecruitingNCT06428045Phase 1
- Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus ErythematosusNot yet recruitingNCT06356740Phase 2
- Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV InfectionCompletedNCT02384395Not applicableResults posted
- A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)CompletedNCT01910402Phase 3Results posted
- Study of Options for Second-Line Effective Combination Therapy (SELECT)CompletedNCT01352715Phase 3Results posted
- Treatment Options for Protease Inhibitor-exposed ChildrenCompletedNCT01146873Phase 3Results posted
- Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin TreatmentCompletedNCT01052701Phase 1Results posted
- Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)CompletedNCT00928187Phase 3Results posted
- KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive SubjectsCompletedNCT00549198Phase 4Results posted
- Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 InfectionCompletedNCT00440947Phase 3Results posted
- ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial RegimensCompletedNCT00335322Phase 4Results posted
- Viral Dynamics and Pharmacokinetics of Abacavir and TenofovirCompletedNCT00214890Phase 2Results posted
- Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at BirthCompletedNCT00102960Phase 3Results posted
- Triumeq in Amyotrophic Lateral SclerosisTerminatedNCT05193994Phase 3
- Inhibition of Reverse Transcription in Aicardi-Goutières SyndromeCompletedNCT04731103Phase 2
- Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject DrugsTerminatedNCT02659761Phase 4
- Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive AdultsTerminatedNCT02182765Phase 1
- Tenofovir Abacavir Platelet Activation StudyCompletedNCT02093585Phase 4
- Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD)CompletedNCT02067767Phase 2
- A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)CompletedNCT01900106Phase 3
- Determining the Effect of Abacavir on Platelet ActivationCompletedNCT01886638Phase 4
- Abacavir and Lamivudine PK in ChildrenCompletedNCT01656122Phase 2/3
- Evaluation of the Bioequivalence of a Combined Formulated TabletCompletedNCT01622790Phase 1
- Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination TabletsCompletedNCT01366547Phase 1
- Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Tenofovir To Abacavir In Hiv-1-Infected Subjects With Loss Of Bone Mineral DensityCompletedNCT01153217Phase 3
- Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected PatientsCompletedNCT01059422Phase 4
- A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in ZimbabweCompletedNCT00834457Phase 2/3
- Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected SubjectsStatus unknownNCT00740064Phase 4
- Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected PatientsCompletedNCT00647244Phase 4
- Comparison of Epzicom and Truvada for the Initial Once Daily HIV TreatmentCompletedNCT00544128Phase 4
- Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.TerminatedNCT00386659Phase 4
- Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir HypersensitivityCompletedNCT00340080Phase 4
- Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TCCompletedNCT00338390Phase 3
- Pharmacokinetic Study Of EPZICOM TabletCompletedNCT00337922Phase 4
- To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and TenofovirCompletedNCT00335192Phase 4
- Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected SubjectsCompletedNCT00320307Phase 1
- Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once DailyCompletedNCT00314626Phase 3
- Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART.CompletedNCT00270556Phase 2
- When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)CompletedNCT00234091Phase 3
- A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL StudyCompletedNCT00192634Phase 4
- D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)CompletedNCT00143702Phase 2/3
- Blood Levels of Abacavir in HIV Infected AdolescentsCompletedNCT00087945Not applicable
- A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced PatientsCompletedNCT00046176Phase 3
- Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV TreatmentWithdrawnNCT00021489Phase 2
- Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsStatus unknownNCT00011895Phase 4
- Blood Levels of Abacavir After One Dose in HIV-Infected Children and AdolescentsCompletedNCT00011479Phase 1
- Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral DrugsStatus unknownNCT00009061Phase 3
- Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected PatientsCompletedNCT00006617Not applicable
- A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected PatientsCompletedNCT00005106Phase 4
- Safety and Effectiveness of a Combination Anti-HIV Drug TreatmentCompletedNCT00005018Phase 4
- Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)Status unknownNCT00004981Phase 3
- Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV DrugsCompletedNCT00004855Not applicable
- A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected AdultsCompletedNCT00004585Phase 4
- A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include AmprenavirCompletedNCT00002423Phase 2
- Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor TreatmentCompletedNCT00002419Phase 2
- The Effect of Teaching HIV-Infected Patients About HIV and TreatmentCompletedNCT00002409Phase 3
- A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected PatientsCompletedNCT00002390Phase 2
- A Study of 1592U89 in HIV-Infected PatientsCompletedNCT00002388Phase 1
- A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV DrugsCompletedNCT00002364Phase 2
- A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsSuspendedNCT00002362Phase 3
- A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected AdultsCompletedNCT00002239Phase 2
- A Study of a Combination of Four Drugs in Patients With Recent HIV InfectionCompletedNCT00002233Phase 2
- A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV DrugsCompletedNCT00002217Not applicable
- An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment RegimenCompletedNCT00002205Not applicable
- A Study of 1592U89 in HIV-Infected AdultsCompletedNCT00002200Not applicable
- A Study of 1592U89 and Ethanol When Given Together to HIV-Infected PatientsCompletedNCT00002198Phase 1
- A Study of 1592U89 in HIV-Infected ChildrenCompletedNCT00002197Not applicable
- A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia ComplexCompletedNCT00002163Phase 3
- A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89CompletedNCT00002141Phase 1
- Once-Daily Drug Regimen for HIV-Infected PatientsCompletedNCT00001968Phase 1
- Continued Antiretroviral Therapy With Abacavir, Amprenavir and EfavirenzCompletedNCT00001758Phase 2
- Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug CombinationCompletedNCT00001132Phase 2
- A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected PatientsCompletedNCT00001086Phase 2
- Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIVCompletedNCT00000940Phase 2
- A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive PatientsCompletedNCT00000912Phase 2
- A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected WomenCompletedNCT00000864Phase 1